McKesson Corporation (MCK) Receives ‘Analyst’ Rating

McKesson Corporation (MCK) : 5 brokerage houses believe that McKesson Corporation (MCK) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. 5 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on McKesson Corporation (MCK). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 11 Wall Street Analysts endorse the stock as a Buy with a rating of 1.95.

McKesson Corporation (MCK) has been rated by 9 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $230 and the lowest price target forecast is $172. The average forecast of all the analysts is $206.11 and the expected standard deviation is $16.41.


Also, JP Morgan maintains its view on McKesson Corporation (NYSE:MCK) according to the research report released by the firm to its investors. The shares have now been rated Overweight by the stock experts at the ratings house. JP Morgan raises the price target from $210 per share to $221 per share on McKesson Corporation. The rating by the firm was issued on August 9, 2016.

McKesson Corporation (NYSE:MCK): After opening at $167.84, the stock dipped to an intraday low of $163.97 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $169.835 and the buying power remained strong till the end. The stock closed at $168.97 for the day, a gain of 0.76% for the day session. The total traded volume was 5,116,645. The stocks close on the previous trading day was $167.7.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.